The make DEEP Human Families Blog

Posts

June 05, 2026

New diabetes clinical trial: BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes

Published on: 2026-06-05T04:00:00Z Conditions : Type 2 Diabetes Mellitus (T2DM) Interventions : Biological: Bofanglutide; Biological: Semaglutide Sponsors : Carnot Laboratories Not yet recruiting https://ift.tt/djeHNto

Search This Blog

The make DEEP Human Families Blog

Posts

UI Health Collaborations and Education

Helping the Crippled 2 God

The Temple of TRANCE Health Portal

TRANCEatable by Pharmakon Health Cloud

Emergent APHID Helpful Resources

Make DEEP Humans a Divided Line

Computational Arrays and Objects for Scientific and Med Lab Research Featured Post

New diabetes clinical trial: BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes

Latest Posts

New diabetes clinical trial: To Assess the Prevalence, Management Practices, and Clinical Outcomes Associated With Hyperglycemia Among Hospitalized Patients, With a Particular Focus on the Interplay Between Metabolic Biomarkers, Nutritional Status, and Body Composition

New diabetes clinical trial: SAPI vs SASI in the Management of Morbid Obesity

New diabetes clinical trial: tSCS and AR Training on QoL and Physical Activity in Diabetic Neuropathy Patients

New diabetes clinical trial: HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

New diabetes clinical trial: Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic Patients

New diabetes clinical trial: A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

New diabetes clinical trial: AI-Based Risk Prediction Model for Upper Digestive Tract Cancer

New diabetes clinical trial: Clinical Information System Impact on Hospitalized Patients With Chronic Disease

New diabetes clinical trial: CGM Experience, Preferences & Blood Glucose Parameters

New diabetes clinical trial: Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Risk of Progression Towards DIABETES and Development of Complications. LIPINFAT Diabetes Study.